Structure-Based Prediction of Asparagine and Aspartate Degradation Sites in Antibody Variable Regions
暂无分享,去创建一个
Apollon Papadimitriou | Florian Lipsmeier | Maximiliane Hilger | Patrick Cramer | Hubert Kettenberger | P. Cramer | M. Hilger | H. Kettenberger | J. Sydow | F. Lipsmeier | Vincent Larraillet | Bjoern Mautz | M. Mølhøj | Jan Kuentzer | S. Klostermann | Juergen Schoch | Hans R. Voelger | J. Regula | A. Papadimitriou | Michael Mølhøj | Stefan Klostermann | Jasmin F. Sydow | Vincent Larraillet | Bjoern Mautz | Jan Kuentzer | Juergen Schoch | Joerg T. Regula | Michael Mølhøj
[1] Benjamin E. Deverman,et al. Chronoregulation by Asparagine Deamidation , 2007, Science's STKE.
[2] V. Katta,et al. Identification of isomerization and racemization of aspartate in the Asp-Asp motifs of a therapeutic protein. , 2011, Analytical biochemistry.
[3] Nia Beckley,et al. Isomerization of Asp-Asp motif in model peptides and a monoclonal antibody Fab fragment. , 2013, Journal of pharmaceutical sciences.
[4] Lisa Yan,et al. LOOPER: a molecular mechanics-based algorithm for protein loop prediction. , 2008, Protein engineering, design & selection : PEDS.
[5] Daniel J. Kroon,et al. Identification of Sites of Degradation in a Therapeutic Monoclonal Antibody by Peptide Mapping , 1992, Pharmaceutical Research.
[6] T. Ueda,et al. Isolation and characterization of 101-succinimide lysozyme that possesses the cyclic imide at Asp101-Gly102. , 1994, Biochemistry.
[7] Z. Shahrokh,et al. Peptide mapping with liquid chromatography using a basic mobile phase. , 2008, Journal of chromatography. A.
[8] B. Kabakoff,et al. Identification of multiple sources of charge heterogeneity in a recombinant antibody. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[9] T. Furuchi,et al. Suppression of protein l-isoaspartyl (d-aspartyl) methyltransferase results in hyperactivation of EGF-stimulated MEK-ERK signaling in cultured mammalian cells. , 2008, Biochemical and biophysical research communications.
[10] Yi-Zeng Liang,et al. Monte Carlo cross validation , 2001 .
[11] R. Borchardt,et al. Reactivity toward deamidation of asparagine residues in beta-turn structures. , 2000, The journal of peptide research : official journal of the American Peptide Society.
[12] John F. Valliere-Douglass,et al. Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometry. , 2008, Analytical chemistry.
[13] K. Lampi,et al. Deamidation destabilizes and triggers aggregation of a lens protein, βA3‐crystallin , 2008, Protein science : a publication of the Protein Society.
[14] J. Kindrachuk,et al. The Influence of Protein Structure on the Products Emerging from Succinimide Hydrolysis* , 2002, The Journal of Biological Chemistry.
[15] Janice M Reichert,et al. Monoclonal antibody successes in the clinic , 2005, Nature Biotechnology.
[16] Wei Zhang,et al. Analysis of isoaspartate in a recombinant monoclonal antibody and its charge isoforms. , 2003, Journal of pharmaceutical and biomedical analysis.
[17] T. Hoffmann,et al. Isoaspartate residues dramatically influence substrate recognition and turnover by proteases , 2008, Biological chemistry.
[18] Vasumathi Dharmavaram,et al. Multivariate Analysis of the Sequence Dependence of Asparagine Deamidation Rates in Peptides , 2009, Pharmaceutical Research.
[19] R. Ionescu,et al. Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods. , 2008, Current pharmaceutical biotechnology.
[20] A. Rees,et al. Antibody variable regions: toward a unified modeling method. , 2004, Methods in molecular biology.
[21] Yaning Wang,et al. Accurate determination of succinimide degradation products using high fidelity trypsin digestion peptide map analysis. , 2011, Analytical chemistry.
[22] R. Borchardt,et al. Chemical Pathways of Peptide Degradation. VI. Effect of the Primary Sequence on the Pathways of Degradation of Aspartyl Residues in Model Hexapeptides , 1994, Pharmaceutical Research.
[23] S Capasso. Estimation of the deamidation rate of asparagine side chains. , 2000, The journal of peptide research : official journal of the American Peptide Society.
[24] A. Kossiakoff,et al. Tertiary structure is a principal determinant to protein deamidation. , 1988, Science.
[25] R. Borchardt,et al. Chemical Pathways of Peptide Degradation. IV. Pathways, Kinetics, and Mechanism of Degradation of an Aspartyl Residue in a Model Hexapeptide , 2004, Pharmaceutical Research.
[26] E. Topp,et al. Effect of protein structure on deamidation rate in the Fc fragment of an IgG1 monoclonal antibody , 2009, Protein science : a publication of the Protein Society.
[27] R. Bischoff,et al. Deamidation of asparagine and glutamine residues in proteins and peptides: structural determinants and analytical methodology. , 1994, Journal of chromatography. B, Biomedical applications.
[28] D. Chelius,et al. 18O labeling method for identification and quantification of succinimide in proteins. , 2007, Analytical chemistry.
[29] H. Scheraga,et al. Stepwise deamidation of ribonuclease A at five sites determined by top down mass spectrometry. , 2006, Biochemistry.
[30] Alain Van Dorsselaer,et al. Characterization of therapeutic antibodies and related products. , 2013, Analytical chemistry.
[31] J. M. Beals,et al. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS. , 2005, Analytical chemistry.
[32] Alain Beck,et al. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. , 2009, Analytical biochemistry.
[33] S. Clarke,et al. Spontaneous degradation of polypeptides at aspartyl and asparaginyl residues: Effects of the solvent dielectric , 1993, Protein science : a publication of the Protein Society.
[34] Jack Y. Zheng,et al. Influence of pH, buffer species, and storage temperature on physicochemical stability of a humanized monoclonal antibody LA298. , 2006, International journal of pharmaceutics.
[35] R Tyler-Cross,et al. Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides. , 1991, The Journal of biological chemistry.
[36] S. Weintraub,et al. Asparagine deamidation: a regulatory hourglass , 2004, Mechanisms of Ageing and Development.
[37] Characterization of the Isomerization Products of Aspartate Residues at Two Different Sites in a Monoclonal Antibody , 2011, Pharmaceutical Research.
[38] A. Lesk,et al. Standard conformations for the canonical structures of immunoglobulins. , 1997, Journal of molecular biology.
[39] Jan H. Jensen,et al. Very fast empirical prediction and rationalization of protein pKa values , 2005, Proteins.
[40] A. Rees,et al. Antibody Variable Regions , 2004 .
[41] Bernhardt L. Trout,et al. Design of therapeutic proteins with enhanced stability , 2009, Proceedings of the National Academy of Sciences.
[42] Ellen M. Langer,et al. Bcl-xL Deamidation Is a Critical Switch in the Regulation of the Response to DNA Damage , 2002, Cell.
[43] D. Chelius,et al. Accumulation of Succinimide in a Recombinant Monoclonal Antibody in Mildly Acidic Buffers Under Elevated Temperatures , 2007, Pharmaceutical Research.
[44] Viktorya Aviyente,et al. Deamidation of asparagine residues: direct hydrolysis versus succinimide-mediated deamidation mechanisms. , 2009, The journal of physical chemistry. A.
[45] S. Clarke,et al. Effect of adjacent histidine and cysteine residues on the spontaneous degradation of asparaginyl- and aspartyl-containing peptides. , 2009, International journal of peptide and protein research.
[46] B. Yan,et al. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain. , 2009, Journal of pharmaceutical sciences.
[47] Richard J Simpson,et al. Stabilization of proteins for storage. , 2010, Cold Spring Harbor protocols.
[48] H. Wright. Sequence and structure determinants of the nonenzymatic deamidation of asparagine and glutamine residues in proteins. , 1991, Protein engineering.
[49] R. Zhao,et al. An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation. , 2004, Cancer cell.
[50] M. Matsumura,et al. Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activity. , 2008, Biochemistry.
[51] A. Green,et al. DNA Damage–Induced Bcl-xL Deamidation Is Mediated by NHE-1 Antiport Regulated Intracellular pH , 2006, PLoS biology.
[52] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[53] Gang Xiao,et al. Identification and quantification of degradations in the Asp-Asp motifs of a recombinant monoclonal antibody. , 2008, Journal of pharmaceutical and biomedical analysis.
[54] J. Shao. Linear Model Selection by Cross-validation , 1993 .
[55] S. Clarke,et al. Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. , 1989, The Journal of biological chemistry.
[56] M. Mølhøj,et al. Simultaneous Assessment of Asp Isomerization and Asn Deamidation in Recombinant Antibodies by LC-MS following Incubation at Elevated Temperatures , 2012, PloS one.
[57] Patrick G. Swann,et al. Considerations for the development of therapeutic monoclonal antibodies. , 2008, Current opinion in immunology.
[58] N. Robinson,et al. Prediction of protein deamidation rates from primary and three-dimensional structure , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[59] A. D. Nielsen,et al. Stability of monoclonal antibodies at high-concentration: head-to-head comparison of the IgG1 and IgG4 subclass. , 2014, Journal of pharmaceutical sciences.
[60] Margit Jeschke,et al. Determination of the Origin of Charge Heterogeneity in a Murine Monoclonal Antibody , 2000, Pharmaceutical Research.
[61] A Tramontano,et al. Conformations of the third hypervariable region in the VH domain of immunoglobulins. , 1998, Journal of molecular biology.
[62] Kurt Hornik,et al. kernlab - An S4 Package for Kernel Methods in R , 2004 .
[63] N. Robinson,et al. Protein deamidation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[64] D. Urry,et al. Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins. , 1991, Critical reviews in biochemistry and molecular biology.
[65] R. Schowen,et al. Secondary structure and protein deamidation. , 1999, Journal of pharmaceutical sciences.
[66] S. Clarke. Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. , 2009, International journal of peptide and protein research.
[67] D. Hambly,et al. Detection and quantitation of IgG 1 hinge aspartate isomerization: a rapid degradation in stressed stability studies. , 2009, Analytical chemistry.
[68] Tilman Schlothauer,et al. Assessment of chemical modifications of sites in the CDRs of recombinant antibodies , 2014, mAbs.
[69] T. Hoffmann,et al. Isoaspartate-containing amyloid precursor protein-derived peptides alter efficacy and specificity of potential β-secretases , 2008, Biological chemistry.
[70] Kurt Hornik,et al. Misc Functions of the Department of Statistics (e1071), TU Wien , 2014 .
[71] William N. Venables,et al. Modern Applied Statistics with S , 2010 .
[72] A. Lesk,et al. Conformations of immunoglobulin hypervariable regions , 1989, Nature.
[73] Andrew J. Martin,et al. Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies. , 1996, Journal of molecular biology.
[74] Aditya A Wakankar,et al. The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibody. , 2007, Journal of pharmaceutical sciences.
[75] N. Robinson,et al. Molecular clocks. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[76] Claus Weihs,et al. klaR Analyzing German Business Cycles , 2005, Data Analysis and Decision Support.
[77] N. Robinson,et al. Deamidation of human proteins , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[78] K. Lampi,et al. Deamidation alters the structure and decreases the stability of human lens betaA3-crystallin. , 2007, Biochemistry.
[79] Ronald T Borchardt,et al. Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization. , 2006, Journal of pharmaceutical sciences.
[80] Hongcheng Liu,et al. Characterization of the stability of a fully human monoclonal IgG after prolonged incubation at elevated temperature. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[81] Douglas S Rehder,et al. Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies. , 2005, Analytical chemistry.
[82] R. Zubarev,et al. Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides , 2010, Electrophoresis.
[83] R. Borchardt,et al. Chemical Pathways of Peptide Degradation. VII. Solid State Chemical Instability of an Aspartyl Residue in a Model Hexapeptide , 1994, Pharmaceutical Research.
[84] Russell Huby,et al. Non-enzymic post-translational modification of proteins in aging. A review , 1989, Mechanisms of Ageing and Development.
[85] R. Borchardt,et al. Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.
[86] D. Brems,et al. The effects of alpha‐helix on the stability of Asn residues: Deamidation rates in peptides of varying helicity , 2008, Protein science : a publication of the Protein Society.
[87] A. B. Robinson,et al. Controlled deamidation of peptides and proteins: an experimental hazard and a possible biological timer. , 1970, Proceedings of the National Academy of Sciences of the United States of America.
[88] S. Clarke,et al. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. , 1987, The Journal of biological chemistry.
[89] L. Presta,et al. Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity. , 1996, Biochemistry.
[90] Y. Matsuoka,et al. Biological significance of isoaspartate and its repair system. , 2005, Biological & pharmaceutical bulletin.
[91] W. Xu,et al. Developability studies before initiation of process development , 2013, mAbs.
[92] Ronald T. Borchardt,et al. Chemical Pathways of Peptide Degradation. II. Kinetics of Deamidation of an Asparaginyl Residue in a Model Hexapeptide , 1990, Pharmaceutical Research.
[93] Ronald T Borchardt,et al. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies. , 2007, Biochemistry.
[94] D. Chelius,et al. Identification and characterization of oxidation and deamidation sites in monoclonal rat/mouse hybrid antibodies. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[95] M. Sawai,et al. Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagon. , 2005, Journal of pharmaceutical sciences.